D. Akin Kurtoglu

D. Akin Kurtoglu is an experienced leader in global business development, currently serving as the Head of Global Business Development, Evaluation, Due Diligence and BD Operations at Ferring Pharmaceuticals since December 2021. Previously, D. Akin Kurtoglu held various roles at Novo Nordisk from January 2008 to December 2021, including Commercial Business Development/New Product Planning Global Lead, where D. Akin Kurtoglu successfully facilitated business development projects and collaborated extensively across multiple functions. Additional prior experience includes positions at Pfizer as an Anti-infectives Product Manager, Gendarmerie General Command as a Lieutenant, EY as a Mergers & Acquisitions Business Analyst, and Mercedes-Benz Türk A.Ş. as a Project Team Lead. Education includes a Master of Science in Finance and Economics from The London School of Economics and Political Science, leadership training from London Business School, and a Bachelor of Science in Industrial Engineering from Boğaziçi University.